CMS certification 030014
Honor Health John C. Lincoln Medical Center
250 East Dunlap Avenue, Phoenix, AZ 85020
Honor Health John C. Lincoln Medical Center has a CMS overall rating of 3 out of 5 stars. 72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 3. Emergency patients spend a median of 3 h 10 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 576 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | AZ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 375 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 10 min | 2 h 56 min | 2 h 42 min |
| Left before being seen Lower is better · 88,152 patients | 2% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 12 patients | 83% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 172 patients | 64% | 59% | 65% |
How Honor Health John C. Lincoln Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Honor Health John C. Lincoln Medical CenterThis hospital | 3/5 | 72% | 3 h 10 min | 5 better 3 worse |
| Phoenix Indian Medical CenterSame city | Not rated | 70% | — | No different |
| Abrazo Central CampusSame city | 2/5 | 54% | 2 h 34 min | 2 better |
| The Core Institute Specialty HospSame city | Not rated | 75% | — | 1 better |
| Honorhealth Deer Valley Medical CenterSame city | 3/5 | 72% | 3 h 14 min | 2 better 1 worse |
| St Josephs Hospital and Medical CenterSame city | 4/5 | 75% | 2 h 55 min | 4 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Phoenix.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 3,089 cases | Too few cases | 3.6% | 3.9% |
| Heart attack 114 cases | Too few cases | 10.6% | 11.9% |
| Heart failure 206 cases | Too few cases | 9.5% | 11.1% |
| Pneumonia 367 cases | Too few cases | 14.2% | 15.2% |
| Stroke 176 cases | Too few cases | 12.3% | 11.9% |
| COPD 86 cases | Too few cases | 8.4% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.98 likely 0.64 – 1.32 | 1 |
| After hip or knee replacement 53 cases | Too few cases | 4.5% | 4.1% |
| Deaths after a serious but treatable surgical complication 77 cases | No different | 136.76 per 1,000 likely 84.13 per 1,000 – 189.4 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,188 cases | No different | 0.2 per 1,000 likely 0 per 1,000 – 0.95 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 5,139 cases | No different | 0.16 per 1,000 likely 0 per 1,000 – 0.37 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 5,188 cases | No different | 0.22 per 1,000 likely 0.03 per 1,000 – 0.42 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,254 cases | No different | 2.06 per 1,000 likely 0.54 per 1,000 – 3.58 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 538 cases | No different | 1.91 per 1,000 likely 0.27 per 1,000 – 3.54 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 551 cases | No different | 10.75 per 1,000 likely 3.55 per 1,000 – 17.95 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,319 cases | No different | 4.92 per 1,000 likely 2.87 per 1,000 – 6.97 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 532 cases | No different | 5.43 per 1,000 likely 1.64 per 1,000 – 9.23 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 375 cases | Worse | 3.29 per 1,000 likely 1.8 per 1,000 – 4.77 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,038 cases | No different | 1.1 per 1,000 likely 0.11 per 1,000 – 2.08 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.42 likely 0.15 – 0.93 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.61 likely 0.27 – 1.2 | 1 |
| Surgical site infections after colon surgery | Worse | 3.09 likely 1.86 – 4.85 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.54 likely 0.39 – 4.18 | 1 |
| MRSA bloodstream infections | No different | 0.83 likely 0.27 – 2.01 | 1 |
| C. diff intestinal infections | Better | 0.18 likely 0.07 – 0.38 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 208 cases | Too few cases | 14.7% | 14.4% |
| Readmitted after heart failure 434 cases | Too few cases | 20.3% | 21.3% |
| Readmitted after pneumonia 739 cases | Too few cases | 15.8% | 17.3% |
| Readmitted after COPD 206 cases | Too few cases | 20.1% | 20% |
| Readmitted after hip or knee replacement 56 cases | Too few cases | 6.9% | 5.8% |
| Days back in hospital after a heart attack 113 cases | Too few cases | 3.5 days per 100 | — |
| Days back in hospital after heart failure 238 cases | Too few cases | 12.4 days per 100 | — |
| Days back in hospital after pneumonia 376 cases | Too few cases | -9.7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 313 cases | No different | 12.6 per 1,000 likely 9.5 per 1,000 – 16.9 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,267 cases | No different | 12.1 per 100 likely 10.6 per 100 – 13.8 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,267 cases | No different | 5.2 per 100 likely 4.2 per 100 – 6.3 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 473 cases | No different | 1.1 likely 0.8 – 1.4 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
114 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Emergency Medicine | 23 |
| Anesthesiology | 18 |
| Internal Medicine | 18 |
| Acute Care | 9 |
| Hospitalist | 9 |
| Family | 4 |
| Family Medicine | 4 |
| Neurocritical Care | 4 |
| Physical Therapist | 4 |
| Registered Nurse | 3 |
| Critical Care Medicine | 2 |
| Medical-Surgical | 2 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.6M
- 2020 $764,683
- 2021 $925,054
- 2022 $1.6M
- 2023 $1.7M
- 2024 $806,354
- 2025 $2.2M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $98,157 | 23 |
| Space rental and facility fees | $7,604 | 7 |
| Debt forgiveness | $23 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Eli Lilly and Company | $352,014 | 3 |
| GT Medical Technologies, Inc | $241,216 | 108 |
| Genentech, Inc. | $235,938 | 22 |
| Boston Scientific Corporation | $199,634 | 36 |
| Jazz Pharmaceuticals INC. | $190,745 | 1 |
| Novocure Inc. | $152,217 | 3 |
| Genmab U.S., Inc. | $112,164 | 10 |
| Abbott Laboratories | $108,414 | 36 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A FIRST IN HUMAN PHASE 1A AND 1B TRIAL TO ASSESS THE SAFETY TOLERABILITY AND PRELIMINARY EFFICACY OF LY4170156 AN ANTIBODY DRUG CONJUGATE TARGETING F… Eli Lilly and Company · NCT06400472 | $333,853 |
| GDC 2992 Ph1 in mCRPC Genentech, Inc. | $235,938 |
| GTM-103 GT Medical Technologies, Inc | $212,325 |
| A Phase II Pilot Clinical Trial of Lurbinectedin (Zepzelca PM01183) in Patients With Gastrointestinal Malignancies With DNA Repair Mutations JAZZ PHARMACEUTICALS INC. | $190,745 |
| Pilot Study of TTFields in combination with nivolumab plus ipilimumab in metastatic uveal melanoma Novocure Inc. | $152,217 |
| Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors Genmab U.S., Inc. | $112,164 |
| A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEv… CSL Behring · NCT03805789 | $96,100 |
| SIMPLAAFY Boston Scientific Corporation · NCT06521463 | $85,370 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Honor Health John C. Lincoln Medical Center
Is Honor Health John C. Lincoln Medical Center a good hospital?
Honor Health John C. Lincoln Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Honor Health John C. Lincoln Medical Center?
72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 576 completed HCAHPS surveys.
How long is the wait in the Honor Health John C. Lincoln Medical Center emergency room?
Emergency patients spend a median of 3 h 10 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Honor Health John C. Lincoln Medical Center receive money from drug and device companies?
Drug and device makers reported $2.2M in payments to Honor Health John C. Lincoln Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.